Loading
companiesCompany
TerraPower Isotopes
Bill Gates-backed producer of actinium-225 from thorium-229, building a Philadelphia facility to raise supply 20-fold.
Overview
TerraPower Isotopes, based in Bellevue, Washington, is the Bill Gates-backed producer of actinium-225 from thorium-229, building a Philadelphia facility intended to raise supply twenty-fold. It obtains actinium-225 from the decay of thorium-229 recovered from a legacy uranium-233 stockpile and holds supply agreements with Bayer, Bristol Myers Squibb and others. OnCo links it to targeted alpha therapy, alpha-emitter nanogenerators and the therapeutic isotope supply chain, to the radiopharmaceutical roadmap from iodine to actinium, and to the idea of recovering legacy radium-226 sources worldwide as feedstock. Manufacturing cost and time for radioactive medicines is the bottleneck it exists to relieve. Whether supply can grow fast enough for the alpha therapies now in phase 3 is the open question.
Headquarters
Bellevue, WA, US
Manufacturing
Capacity map- TerraPower Isotopes Philadelphia Philadelphia, Pennsylvania, USRadioisotope production
Website
Similar pages
- CompanyOrano Med
Shares Recover legacy radium-226 sources worldwide as the feedstock for actinium-225, Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225 supply: thorium stocks, accelerators and radium targets, Radiopharmaceutical roadmap: iodine → lutetium → actinium.
- CompanyITM Isotope Technologies Munich
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225 supply: thorium stocks, accelerators and radium targets, Radiopharmaceutical roadmap: iodine → lutetium → actinium, Targeted alpha therapy.
- CompanyNorthStar Medical Radioisotopes
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225 supply: thorium stocks, accelerators and radium targets.
- CompanyNusano
Shares Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225 supply: thorium stocks, accelerators and radium targets.
- TreatmentActinium-225 PSMA agents
Shares Recover legacy radium-226 sources worldwide as the feedstock for actinium-225, Actinium-225 supply: thorium stocks, accelerators and radium targets, Radiopharmaceutical roadmap: iodine → lutetium → actinium, Targeted alpha therapy.
- TreatmentActinium-225 DOTATATE
Shares Recover legacy radium-226 sources worldwide as the feedstock for actinium-225, Actinium-225 supply: thorium stocks, accelerators and radium targets, Radiopharmaceutical roadmap: iodine → lutetium → actinium, Targeted alpha therapy.
- CompanyRayzeBio (BMS)
Shares Actinium-225 supply: thorium stocks, accelerators and radium targets, Radiopharmaceutical roadmap: iodine → lutetium → actinium, Targeted alpha therapy.
- CompanyFusion Pharmaceuticals (AstraZeneca)
Shares Radiopharmaceutical roadmap: iodine → lutetium → actinium, Targeted alpha therapy.